retatrutide a1c Lilly's triple agonist achieves 16.8% weight loss in phase 3 trial New Kind of Diabetes Drug

This year, one of the most critical thinkers about statistics and life, Professor Scott Galloway, offered his forecast for 2024 including a major tea-leaf reading that the GLP-1 agonists would be a more impactful trend in 2024 than Gen AI would be

This highlights the potential of microbiota-targeted interventions to mitigate CVD risk by maintaining immune and metabolic homeostasis

This procedure can remove submucosal fibroids, but not intramural or subserosal fibroids

Figure 2 Table 1 Properties of DTEase family enzymes

However, the ability to use very high doses of small molecule antioxidants like vitamin E for extended periods of times may be limited by the toxicity of these high doses (392)

The hippocampus of exercised rats showed significantly reduced ROS levels and protein carbonyl content compared to sedentary controls